SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management

Data to be presented will highlight the progress of SAB BIO’s lead program, SAB-142, a potentially best-in-class, disease-modifying, redosable immunotherapy in clinical development for delaying the ...

From Novel Therapies to First-in-Human Trials, City of Hope Advances Blood Cancer Care at the American Society of Hematology (ASH) Annual Conference

A combination of two therapies, azacitidine and venetoclax, or aza-ven, outperformed intensive chemotherapy for acute myeloid leukemia in patients healthy enough to receive aggressive treatment, ...
Science Daily

Gut molecule shows remarkable anti-diabetes power

Researchers revealed that the microbial metabolite TMA can directly block the immune protein IRAK4, reducing inflammation and ...

Microbial molecule that disarms inflammation discovered, offering new diabetes treatment strategy

An international research team has uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a ...
Nature

‘Giant step forward’ for Huntington’s — the scientist behind the first gene therapy

On a video call in early September, Sarah Tabrizi first saw the data that she and other researchers studying Huntington’s ...